Eton Pharmaceuticals, Inc.
ETON · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $37 | $25 | $17 | $15 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $13 | $14 | $16 | $5 |
| Inventory | $17 | $24 | $14 | $15 |
| Other Curr. Assets | $5 | $5 | $3 | $5 |
| Total Curr. Assets | $72 | $68 | $50 | $41 |
| Property Plant & Equip (Net) | $1 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $32 | $33 | $34 | $35 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $33 | $33 | $34 | $35 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $105 | $102 | $84 | $76 |
| Liabilities | – | – | – | – |
| Payables | $14 | $12 | $5 | $4 |
| Short-Term Debt | $3 | $3 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $27 | $23 | $0 | $16 |
| Total Curr. Liab. | $44 | $39 | $25 | $20 |
| LT Debt | $0 | $27 | $30 | $30 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $37 | $11 | $4 | $2 |
| Total NC Liab. | $37 | $39 | $34 | $32 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $81 | $78 | $60 | $52 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$114 | -$112 | -$109 | -$108 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $137 | $0 | $0 | $0 |
| Total Equity | $23 | $24 | $24 | $24 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $105 | $102 | $84 | $76 |
| Net Debt | -$34 | $5 | $13 | $15 |